Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma

Published:2011-05-02 Issue:6 Volume:53 Page:1943-1958
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Omar Hany A.,Chou Chih-Chien,Berman-Booty Lisa D.,Ma Yihui,Hung Jui-Hsiang,Wang Dasheng,Kogure Takayuki,Patel Tushar,Terracciano Luigi,Muthusamy Natarajan,Byrd John C.,Kulp Samuel K.,Chen Ching-Shih

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24293/fullpdf

Reference28 articles.

1. Pathogenesis of hepatocellular carcinoma;Moradpour;Eur J Gastroenterol Hepatol,2005

2. Opportunities for targeted therapies in hepatocellular carcinoma;Thomas;J Clin Oncol,2005

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

5. “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets;Takabe;Pharmacol Rev,2008

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative roles of sphingosine kinase in liver pathophysiology;Toxicological Research;2023-06-19

2. Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge;Biological Procedures Online;2022-12-03

3. Retracted: Antitumor effects of OSU‐2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma;Hepatology;2022-09-08

4. Sphingosine‐1‐phosphate in mitochondrial function and metabolic diseases;Obesity Reviews;2022-02-05

5. Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer;World Journal of Gastroenterology;2022-01-14